A pilot study of plasma interleukin-6 and interleukin-27 in differential diagnosis of acute respiratory distress syndrome and neonatal respiratory distress syndrome in preterm infants
LIU Chan, HE Yu, AI Qing, SHI Yuan
Neonatal Diagnosis and Treatment Center, Children's Hospital of Chongqing Medical University/National Clinical Research Center for Child Health and Disorders/Ministry of Education Key Laboratory of Child Development and Disorders/China International Science and Technology Cooperation Base of Child Development and Critical Disorders/Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
Abstract：Objective To study the significance of interleukin-6 (IL-6) and interleukin-27 (IL-27) in the differential diagnosis of acute respiratory distress syndrome (ARDS) and neonatal respiratory distress syndrome (NRDS) in preterm infants. Methods The preterm infants with the manifestation of respiratory distress who were treated in the Neonatal Diagnosis and Treatment Center, Children's Hospital of Chongqing Medical University, from March to November 2021, were enrolled in this prospective study. According to the diagnosis results, they were divided into two groups: ARDS group (n=18) and NRDS group (n=20). ELISA was used to measure the plasma levels of IL-6 and IL-27. The receiver operating characteristic (ROC) curve was used to analyze the value of each index in the diagnosis of ARDS. Results The ARDS group had significantly higher plasma levels of IL-6 and IL-27 than the NRDS group (P<0.05). The ROC curve analysis showed that IL-6 had an area under the ROC curve (AUC) of 0.867 for the diagnosis of ARDS, with a sensitivity of 61.1% and a specificity of 95.0% at the cut-off value of 56.21 pg/mL. The ROC curve analysis also showed that IL-27 had an AUC of 0.881 for the diagnosis of ARDS, with a sensitivity of 83.3% and a specificity of 80.0% at the cut-off value of 135.8 pg/mL. Conclusions Plasma IL-6 and IL-27 can be used as biological indicators for early differential diagnosis of ARDS and NRDS in preterm infants.
LIU Chan,HE Yu,AI Qing et al. A pilot study of plasma interleukin-6 and interleukin-27 in differential diagnosis of acute respiratory distress syndrome and neonatal respiratory distress syndrome in preterm infants[J]. CJCP, 2022, 24(4): 428-432.
Wang J, Liu X, Zhu T, et al. Analysis of neonatal respiratory distress syndrome among different gestational segments[J]. Int J Clin Exp Med, 2015, 8(9): 16273-16279. PMID: 26629144. PMCID: PMC4659032.
3 Qaril SA, Alsufyani AA, Muathin SH, et al. Prevalence of respiratory distress syndrome in neonates[J]. Egypt J Hosp Med, 2018, 70(2): 257-264. DOI: 10.12816/0043086.
De Luca D, van Kaam AH, Tingay DG, et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity[J]. Lancet Respir Med, 2017, 5(8): 657-666. PMID: 28687343. DOI: 10.1016/S2213-2600(17)30214-X.
He Y, Du WX, Jiang HY, et al. Multiplex cytokine profiling identifies interleukin-27 as a novel biomarker for neonatal early onset sepsis[J]. Shock, 2017, 47(2): 140-147. PMID: 27648693. DOI: 10.1097/SHK.0000000000000753.
Mihara M, Hashizume M, Yoshida H, et al. IL-6/IL-6 receptor system and its role in physiological and pathological conditions[J]. Clin Sci (Lond), 2012, 122(4): 143-159. PMID: 22029668. DOI: 10.1042/CS20110340.
Voiriot G, Razazi K, Amsellem V, et al. Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury[J]. Respir Res, 2017, 18(1): 64. PMID: 28424078. PMCID: PMC5397701. DOI: 10.1186/s12931-017-0553-6.
Tsantes A, Tsangaris I, Kopterides P, et al. The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study[J]. Clin Chem Lab Med, 2013, 51(7): 1535-1542. PMID: 23314554. DOI: 10.1515/cclm-2012-0562.
Wong HR, Cvijanovich NZ, Hall M, et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children[J]. Crit Care, 2012, 16(5): R213. PMID: 23107287. PMCID: PMC3682317. DOI: 10.1186/cc11847.
